Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride reduces DHT more effectively than finasteride.

The new compound may be a safer alternative to finasteride for prostate protection.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Finasteride may cause sexual dysfunction by reducing epinephrine levels.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Finasteride and dutasteride may cause macular abnormalities.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

BPH treatments can cause sexual side effects affecting quality of life.

Finasteride reduces some inflammation in BPH but not all.

Dutasteride and finasteride have equal safety for treating BPH without increased heart risk.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Saw palmetto helps with nighttime urination and urine flow, similar to finasteride.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Dutasteride and finasteride can change semen and hormone levels in men.

Finasteride improves urinary symptoms and quality of life in BPH patients, especially with larger prostate size.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

In 2005, men used finasteride mainly to treat an enlarged prostate.